Chad Gwaltney

10.3k total citations · 2 hit papers
122 papers, 7.8k citations indexed

About

Chad Gwaltney is a scholar working on Physiology, Applied Psychology and Epidemiology. According to data from OpenAlex, Chad Gwaltney has authored 122 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Physiology, 29 papers in Applied Psychology and 19 papers in Epidemiology. Recurrent topics in Chad Gwaltney's work include Smoking Behavior and Cessation (35 papers), Behavioral Health and Interventions (29 papers) and Substance Abuse Treatment and Outcomes (15 papers). Chad Gwaltney is often cited by papers focused on Smoking Behavior and Cessation (35 papers), Behavioral Health and Interventions (29 papers) and Substance Abuse Treatment and Outcomes (15 papers). Chad Gwaltney collaborates with scholars based in United States, United Kingdom and France. Chad Gwaltney's co-authors include Saul Shiffman, Jean Paty, Mark H. Balabanis, Laurie B. Burke, Mona Martin, Lena Ring, Elizabeth Molsen, Nancy Kline Leidy, Donald L. Patrick and Maryann Gnys and has published in prestigious journals such as Neurology, Journal of Consulting and Clinical Psychology and Journal of Abnormal Psychology.

In The Last Decade

Chad Gwaltney

117 papers receiving 7.6k citations

Hit Papers

Content Validity—Establishing and Reporting the Evidence ... 2011 2026 2016 2021 2011 2011 250 500 750

Peers

Chad Gwaltney
Thomas H. Brandon United States
Jean Paty United States
Christi A. Patten United States
Ulrich John Germany
Craig Whittington United Kingdom
Rosa M. Crum United States
Ellen R. Gritz United States
Deborah J. Bowen United States
Dana H. Bovbjerg United States
Thomas H. Brandon United States
Chad Gwaltney
Citations per year, relative to Chad Gwaltney Chad Gwaltney (= 1×) peers Thomas H. Brandon

Countries citing papers authored by Chad Gwaltney

Since Specialization
Citations

This map shows the geographic impact of Chad Gwaltney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad Gwaltney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad Gwaltney more than expected).

Fields of papers citing papers by Chad Gwaltney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad Gwaltney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad Gwaltney. The network helps show where Chad Gwaltney may publish in the future.

Co-authorship network of co-authors of Chad Gwaltney

This figure shows the co-authorship network connecting the top 25 collaborators of Chad Gwaltney. A scholar is included among the top collaborators of Chad Gwaltney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chad Gwaltney. Chad Gwaltney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schiffmann, Raphael, James Turnbull, Ruth Pulikottil-Jacob, et al.. (2025). Gaucher disease type 3 from infancy through adulthood: a conceptual model of signs, symptoms, and impacts associated with ataxia and cognitive impairment. Orphanet Journal of Rare Diseases. 20(1). 171–171. 1 indexed citations
3.
Dimachkie, Mazen M., Priya S. Kishnani, Cristina Ivanescu, et al.. (2023). Measurement Properties of 2 Novel PROs, the Pompe Disease Symptom Scale and Pompe Disease Impact Scale, in the COMET Study. Neurology Clinical Practice. 13(5). e200181–e200181. 6 indexed citations
4.
Kulasekararaj, Austin, Axel Glasmacher, Jeff Szer, et al.. (2022). Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria. European Journal Of Haematology. 108(5). 391–402. 5 indexed citations
5.
Reaney, Matthew, et al.. (2022). Development of an Item Bank to Assess Patient-Reported Outcomes: Signs, Symptoms, and Impacts of COVID-19. Patient. 15(6). 703–713. 1 indexed citations
6.
Mowlem, Florence D., Pamela Tenaerts, Chad Gwaltney, & Ingrid Oakley‐Girvan. (2022). Regulatory Acceptance of Patient-Reported Outcome (PRO) Data from Bring-Your-Own-Device (BYOD) Solutions to Support Medical Product Labeling Claims. Therapeutic Innovation & Regulatory Science. 56(4). 531–535. 6 indexed citations
8.
Niklasson, Anna, et al.. (2022). Living with Heart Failure: Patient Experiences and Implications for Physical Activity and Daily Living. ESC Heart Failure. 9(2). 1206–1215. 17 indexed citations
9.
Pulikottil-Jacob, Ruth, et al.. (2020). Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases. Orphanet Journal of Rare Diseases. 15(1). 92–92. 6 indexed citations
10.
Gwaltney, Chad, Jean Paty, Virginia E. Kwitkowski, et al.. (2017). Development of a harmonized patient-reported outcome questionnaire to assess myelofibrosis symptoms in clinical trials. Leukemia Research. 59. 26–31. 16 indexed citations
11.
Paty, Jean, et al.. (2016). Enhancing Interpretation of Patient-Reported Outcome Scores Through Intuitive Metrics: An Example from Prostate Cancer. Value in Health. 19(3). A160–A160. 1 indexed citations
12.
Gwaltney, Chad, B. Tiplady, & C. Deschaseaux. (2015). Using The Clinical Summary Score From The Kansas City Cardiomyopathy Questionnaire As An Endpoint In Clinical Trials: Psychometric Support. Value in Health. 18(3). A24–A24. 1 indexed citations
13.
Kahler, Christopher W., R. Kathryn McHugh, Adam M. Leventhal, et al.. (2011). High hostility among smokers predicts slower recognition of positive facial emotion. Personality and Individual Differences. 52(3). 444–448. 11 indexed citations
14.
Patrick, Donald L., Laurie B. Burke, Chad Gwaltney, et al.. (2011). Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument. Value in Health. 14(8). 967–977. 787 indexed citations breakdown →
15.
Patrick, Donald L., Laurie B. Burke, Chad Gwaltney, et al.. (2011). Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding. Value in Health. 14(8). 978–988. 805 indexed citations breakdown →
16.
Monti, Peter M., Nancy P. Barnett, Suzanne M. Colby, et al.. (2007). Motivational interviewing versus feedback only in emergency care for young adult problem drinking. Addiction. 102(8). 1234–1243. 178 indexed citations
17.
Shiffman, Saul, Mark H. Balabanis, Chad Gwaltney, et al.. (2007). Prediction of lapse from associations between smoking and situational antecedents assessed by ecological momentary assessment. Drug and Alcohol Dependence. 91(2-3). 159–168. 184 indexed citations
18.
Shiffman, Saul, Deborah M. Scharf, William G. Shadel, et al.. (2006). Analyzing Milestones in Smoking Cessation. 19(5). 690–3. 1 indexed citations
19.
Brandon, Thomas H., Thaddeus A. Herzog, Jennifer E. Irvin, & Chad Gwaltney. (2004). Cognitive and social learning models of drug dependence: implications for the assessment of tobacco dependence in adolescents. Addiction. 99(s1). 51–77. 93 indexed citations
20.
Kamarck, Thomas W., Matthew F. Muldoon, Saul Shiffman, et al.. (2004). Experiences of Demand and Control in Daily Life as Correlates of Subclinical Carotid Atherosclerosis in a Healthy Older Sample.. Health Psychology. 23(1). 24–32. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026